Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TUSSICAPS

CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX

Standard Dose
EQ 8MG MALEATE;EQ 10MG BITARTRATE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TUSSICAPS is listed in Drugs@FDA under application 077273 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX Form and strength CAPSULE, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE;EQ 10MG BITARTRATE Sponsor ECR PHARMA Submission history Latest submission status date: 2014-11-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview TUSSICAPS is listed in Drugs@FDA under application 077273 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX Form and strength CAPSULE, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE;EQ 10MG BITARTRATE Sponsor ECR PHARMA Submission history Latest submission status date: 2014-11-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.